This contributor column discusses a recent study that shows the 340B Program’s explosive growth is overwhelmingly due to ...

Adults with peanut allergy experienced effective treatment with peanut oral immunotherapy but future studies are necessary to ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Developments in artificial intelligence (AI) can help clinicians to diagnose thoracic conditions that may be miss on first glance.

"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

US workers facing high economic hardship, especially those in lower-wage occupations, were significantly more likely to ...

Stem cell transplants could produce promising remission rates for children with severe monogenic inflammatory bowel disease ...

Older adults with cardiovascular disease (CVD) or CVD risk factors report that gaps in communication among their providers are common and hazardous.

Panelists discuss the primary access challenges in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) treatment, including financial barriers and health care system limitations, and how ...

Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre, discusses a phase 3 clinical trial investigating amivantamab in metastatic colorectal cancer.

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.

Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre, discusses a novel adjuvant ...